Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized D...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Res Sq
Hlavní autoři: Chiuppesi, Flavia, Salazar, Marcela d’Alincourt, Contreras, Heidi, Nguyen, Vu, Martinez, Joy, Park, Soojin, Nguyen, Jenny, Kha, Mindy, Iniguez, Angelina, Zhou, Qiao, Kaltcheva, Teodora, Levytskyy, Roman, Ebelt, Nancy, Kang, Tae, Wu, Xiwei, Rogers, Tom, Manuel, Edwin, Shostak, Yuriy, Diamond, Don, Wussow, Felix
Médium: Artigo
Jazyk:Inglês
Vydáno: American Journal Experts 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373143/
https://ncbi.nlm.nih.gov/pubmed/32702732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-40198/v1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky